Integrated Spatial Platform The Ultivue Vizgen merger creates a comprehensive spatial biology portfolio including MERFISH single cell spatial genomics, MERSCOPE platforms, InSituPlex assays and STARVUE AI image analysis. This enables cross sell opportunities to academic labs, translational researchers and pharma and biotech R&D seeking end to end spatial solutions.

Configurable Panels Upsell The launch of configurable multiplex spatial panels provides a growth lever to upsell to existing customers and attract new labs needing customizable multiplex imaging. Sales strategies include pilots with oncology immunotherapy teams and translational research labs, paired with streamlined data analysis options.

Translational Partnerships Past collaborations with Paige and a focus on translational research indicate demand for AI powered biomarker imaging and integrated workflows. Target opportunities include translational research units, clinical research centers and CROs, with potential for joint development and co marketing programs.

AI Analytics Value STARVUE AI powered spatial image analysis adds a strong differentiator. Offer bundled services such as data processing, visualization and interpretation, and pursue managed service contracts that deliver actionable insights to researchers without heavy in house IT burden.

Market Credibility Position as a leading private spatial biology company based in Cambridge with notable funding momentum and leadership growth to engage enterprise customers, grant funded projects and strategic partnerships. Leverage credibility to accelerate introductions and shorten sales cycles.